GlassScriptPhysician profile
Robert F Koerner
NPI 1184605180
$1,977.14
in general payments reported to CMS, 2019-2025
14 companies · $449 in 2025
The $449 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $97.96 · 2021: $155 · 2022: $374 · 2023: $309 · 2024: $250 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,007.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $398.64 | 2020-2025 | Precision 1, Hydrus Microstent, Total30 |
| Coopervision INC. | $353.97 | 2022-2025 | Clariti Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $300.24 | 2022-2025 | Xiidra, Miebo, Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $158.72 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $122.06 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $122.00 | 2022 | |
| Dompe US, INC. | $103.86 | 2025 | Oxervate |
| Optos, INC. | $98.69 | 2019 | |
| Abbvie INC. | $92.08 | 2022-2023 | |
| Kala Pharmaceuticals, INC. | $89.92 | 2021 | |
| Allergan, INC. | $60.33 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $27.77 | 2022 | |
| Abb Con-Cise Optical Group LLC | $27.38 | 2020 | |
| Sight Sciences, INC. | $21.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Koerner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.